AUTH/2116/4/08: General practitioner v Reckitt Benckiser Healthcare – unsolicited promotional email (Gaviscon Advance)

📅 8 March 2026 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2116/4/08
Case referenceGeneral practitioner v Reckitt Benckiser Healthcare
ComplainantA general practitioner
Respondent/companyReckitt Benckiser Healthcare
Product(s)Gaviscon Advance
Material/channelEmail (promotional email sent via an agency)
Key issueUnsolicited promotional email sent after the complainant opted out; third-party agency failed to remove details from its database
Dates (received/completed if stated)Complaint received 21 April 2008; case completed 30 May 2008
AppealNot stated
Code yearNot stated
Breaches/clausesClause 9.9
SanctionsNo explicit additional sanctions stated beyond the required undertaking/corrective actions described in the report

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
📋

What happened

  • A general practitioner complained that he continued to receive spam emails despite having opted out of an agency email service.
  • The complainant had previously complained about unsolicited promotional emails (Cases AUTH/2083/1/08, AUTH/2088/1/08 and AUTH/2089/1/08).
  • The email at issue promoted Gaviscon Advance and was sent on behalf of Reckitt Benckiser Healthcare via an agency.
  • The agency operated an opt-in system and stated that prior permission was sought before promotional material was sent electronically.
  • After the complainant requested removal from the agency database (29 January 2008), a junior staff member became confused and did not remove his details; further emails were then sent, including the sponsored element about Gaviscon Advance.
  • The agency sent the complainant a letter of apology and said it should take full responsibility for the misunderstanding, not Reckitt Benckiser.
⚖️

Outcome

  • The Panel considered the email about Gaviscon Advance to be clearly promotional.
  • The Panel ruled that the email was unsolicited because the complainant had stated he did not want to receive promotional emails.
  • The Panel noted that companies are responsible under the Code for work undertaken by third parties on their behalf.
  • A breach of Clause 9.9 was ruled.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Charter Member — Until 31 March

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export. £1,999/year £2,499

Get Charter Access →

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free